SAN FRANCISCO (MarketWatch) - Amgen Inc. was ordered by regulators to pull a television ad that overstated the effectiveness of its Enbrel psoriasis treatment. See full story. Market Snapshot: U.S.
I'm one of 47,000 Medicare recipients lucky enough to receive a drug that my old rheumatologist, who originally prescribed it for me, described as a miracle. When he was a young doctor, he told me, ...
Enbrel (etanercept) is a prescription brand-name medication. It’s approved by the Food and Drug Administration (FDA) to treat the following conditions: For each of these conditions, Enbrel is ...
SAN FRANCISCO (MarketWatch) - Amgen Inc. was ordered by regulators to pull a television ad that overstated the effectiveness of its Enbrel psoriasis treatment. In a letter to Amgen AMGN Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback